Purchase Order 36C24123P0991

Award Date 8/23/23
Potential Completion Date 8/22/24
Potential Value $57K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Shelton, CT 06484, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 2 has awarded a $56,250 firm fixed price purchase order to Calmare Therapeutics Incorporated for the Calmare Therapy MC-5A, a 5-channel transcutaneous electrical nerve stimulator. The stimulator will provide treatment based on stored programs to support the VA's efforts in providing veterans' healthcare services. Calmare Therapeutics will perform as the prime contractor, delivering the nerve...
The U.S. Defense Health Agency awarded a $56,750 firm fixed price purchase order to Calmare Therapeutics Incorporated, a U.S. biotechnology company, for the delivery of the Calmare pain therapy medical device and related equipment. This award was not set aside. Calmare Therapeutics is the prime contractor and there were no subcontractors mentioned. The Calmare device utilizes transcutaneous electrical nerve stimulation to provide non-opioid pain treatment. This award supports the VA healthcare...
The Department of Veterans Affairs Veterans Health Administration awarded a $56,250 delivery order contract to Calmare Therapeutics Incorporated for its CALMARE PAIN MANAGEMENT solution. Calmare Therapeutics will provide its medical equipment and supplies under the company's GSA Schedule 65-II-A contract vehicle. Performance will take place in Fairfield, Connecticut over a two-month period concluding in late August 2021. The contract has a firm fixed price and supports the VA-VHA's Veterans...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 (VA - VHA VISN 21) awarded a $56,250 purchase order to Calmare Therapeutics Incorporated for a Calmare Pain Therapy Device. The firm fixed price contract is for the procurement of the pain therapy device, a power converter, bifurcated cables, and an initial supply of electrodes. The products and services will be delivered to and used at the VA Southern Nevada Healthcare System facility...
This federal contract award is for the "RATIFICATION OF UNAUTHORIZED COMMITMENT" to Calmare Therapeutics Incorporated, doing business as Calmare Therapeutics. The $2,400.00 firm fixed price purchase order was placed by the U.S. Department of the Navy's Bureau of Medicine and Surgery, a defense agency. The contract supports the provision of Calmare's FDA-cleared pain therapy medical devices, such as the Calmare PMT-1, MC-5A, and Scrambler Therapy models, which utilize transcutaneous...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 1 (VA - VHA VISN 1) awarded a firm fixed price purchase order to Phillips Safety Products, Inc. for the CALMARE PAIN DEVICE. The one-year contract, valued at approximately $500,000 to $1,000,000, runs from August 15, 2023 through August 15, 2024. Phillips Safety Products, Inc. will deliver its CALMARE PAIN DEVICE from its place of performance in Middlesex, New Jersey to support the VA's...
The Department of Veterans Affairs (VA) Veterans Health Administration has awarded a firm fixed-price purchase order contract to Cala Health, Inc. to provide CALA KIQ nerve stimulation bands, CALA KIQ stimulators with charging stations, and related bioelectronic equipment. The $10,160.00 contract is to support veteran healthcare services through VA's Veterans Integrated Service Network 7, with a completion date of July 1, 2024. The award does not have any set-aside designation. As a prime...
This is a firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) to Cala Health, Inc., a for-profit manufacturer of bioelectronic medical devices. The contract, valued at $10,160.00, is for the delivery of 2 CALA Trio Stimulators and 8 CALA Trio Bands to support veteran healthcare services. The CALA Trio system is designed to aid in the treatment of neurological disorders, such as hand tremors. This contract award, issued under the VA's Veterans...
This federal contract award is for the supply of CALA TRIO STIMULATORS AND BANDS to the Veterans Integrated Service Network 15 (VISN 15) of the Department of Veterans Affairs (VA) Veterans Health Administration. The contract was awarded to the prime contractor, Cala Health, Inc., doing business as Cala Health Inc., a for-profit manufacturer of bioelectronic medical devices focused on nerve stimulation technology. The contract has a ceiling value of $10,160.00 and is structured as a firm...
The Department of Veterans Affairs Veterans Health Administration awarded a $36,052.00 firm fixed price purchase order to Medtronic Inc., a global medical device manufacturer, to provide a neurostimulator. This order is part of a larger $600 million Indefinite Delivery Contract between Medtronic and the VA that enables the agency to efficiently procure necessary medical devices and supplies to support healthcare services for veterans across its network of hospitals and clinics. The contract...

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 1 awarded a $57,113.90 firm fixed price purchase order to Calmare Therapeutics Incorporated for the CALMARE SCRAMBLER THERAPY DEVICE. Calmare Therapeutics, doing business as Calmare Therapeutics, will deliver its CALMARE SCRAMBLER THERAPY DEVICE to support VHA programs in Shelton, Connecticut under the one-year contract running from August 2023 through August 2024. The award is not associated with a multiple award contract vehicle. No subcontractors or set-aside designations were identified. The contract will provide Calmare Therapeutics' medical device, which may support VHA's efforts to treat veterans, at the specified location through August 2024.

Generated 12/17/23, 8:36 PM